Literature DB >> 25439270

The interrelationships of the gut microbiome and inflammation in colorectal carcinogenesis.

Margaret Cho1, Janell Carter1, Saul Harari1, Zhiheng Pei2.   

Abstract

The cause of colorectal cancer (CRC) is multifactorial, with genetic, molecular, inflammatory, and environmental risk factors. Recently, the gut microbiota has been recognized as a new environmental contributor to CRC in both animal models and human studies. An additional interplay of the gut microbiome with inflammation is also evident in studies that have shown that inflammation alone or the presence of bacteria/bacterial metabolites alone is not enough to promote tumorigenesis. Rather, complex interrelationships with the gut microbiome, inflammation, genetics, and other environmental factors are evident in progression of colorectal tumors. Published by Elsevier Inc.

Entities:  

Keywords:  Carcinogenesis; Colorectal cancer; Gut microbiome; Inflammation

Mesh:

Year:  2014        PMID: 25439270      PMCID: PMC4254421          DOI: 10.1016/j.cll.2014.08.002

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  86 in total

1.  Biliary bile acid profiles in familial adenomatous polyposis.

Authors:  S Radley; A E Davis; C H Imray; G Barker; D G Morton; P R Baker; J P Neoptolemos
Journal:  Br J Surg       Date:  1992-01       Impact factor: 6.939

Review 2.  Gut microbiota and related diseases: clinical features.

Authors:  Vincenzo Stanghellini; Giovanni Barbara; Cesare Cremon; Rosanna Cogliandro; Alexandra Antonucci; Veronica Gabusi; Chiara Frisoni; Roberto De Giorgio; Valentina Grasso; Mauro Serra; Roberto Corinaldesi
Journal:  Intern Emerg Med       Date:  2010-10       Impact factor: 3.397

3.  Production of cytokines by monocytes, epithelial and endothelial cells activated by Streptococcus bovis.

Authors:  S Ellmerich; N Djouder; M Schöller; J P Klein
Journal:  Cytokine       Date:  2000-01       Impact factor: 3.861

4.  Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer.

Authors:  Wade S Samowitz; Hans Albertsen; Carol Sweeney; Jennifer Herrick; Bette J Caan; Kristin E Anderson; Roger K Wolff; Martha L Slattery
Journal:  J Natl Cancer Inst       Date:  2006-12-06       Impact factor: 13.506

Review 5.  Fusobacterium nucleatum in periodontal health and disease.

Authors:  Benoit Signat; Christine Roques; Pierre Poulet; Danielle Duffaut
Journal:  Curr Issues Mol Biol       Date:  2011-01-10       Impact factor: 2.081

6.  Effects of Lactobacillus rhamnosus GG on proliferation and polyamine metabolism in HGC-27 human gastric and DLD-1 colonic cancer cell lines.

Authors:  Antonella Orlando; Caterina Messa; Michele Linsalata; Aldo Cavallini; Francesco Russo
Journal:  Immunopharmacol Immunotoxicol       Date:  2009       Impact factor: 2.730

7.  Iron-overload induces oxidative DNA damage in the human colon carcinoma cell line HT29 clone 19A.

Authors:  Michael Glei; Gladys O Latunde-Dada; Annett Klinder; Thomas W Becker; Uta Hermann; Klaus Voigt; Beatrice L Pool-Zobel
Journal:  Mutat Res       Date:  2002-08-26       Impact factor: 2.433

Review 8.  The role of the gastrointestinal microbiota in colorectal cancer.

Authors:  Ian R Rowland
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

9.  Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome.

Authors:  L Flanagan; J Schmid; M Ebert; P Soucek; T Kunicka; V Liska; J Bruha; P Neary; N Dezeeuw; M Tommasino; M Jenab; J H M Prehn; D J Hughes
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-06       Impact factor: 3.267

10.  Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential.

Authors:  M Tsujii; S Kawano; R N DuBois
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

View more
  12 in total

1.  Race-dependent association of sulfidogenic bacteria with colorectal cancer.

Authors:  Cemal Yazici; Patricia G Wolf; Hajwa Kim; Tzu-Wen L Cross; Karin Vermillion; Timothy Carroll; Gaius J Augustus; Ece Mutlu; Lisa Tussing-Humphreys; Carol Braunschweig; Rosa M Xicola; Barbara Jung; Xavier Llor; Nathan A Ellis; H Rex Gaskins
Journal:  Gut       Date:  2017-02-02       Impact factor: 23.059

Review 2.  Diet, microorganisms and their metabolites, and colon cancer.

Authors:  Stephen J D O'Keefe
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-11-16       Impact factor: 46.802

Review 3.  Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.

Authors:  Antonio Galvao Neto; April Whitaker; Zhiheng Pei
Journal:  Semin Oncol       Date:  2015-09-07       Impact factor: 4.929

Review 4.  Mechanistic and Technical Challenges in Studying the Human Microbiome and Cancer Epidemiology.

Authors:  Mukesh Verma
Journal:  Technol Cancer Res Treat       Date:  2016-06-22

Review 5.  Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer.

Authors:  Mark Lawler; Deborah Alsina; Richard A Adams; Annie S Anderson; Gina Brown; Nicola S Fearnhead; Stephen W Fenwick; Stephen P Halloran; Daniel Hochhauser; Mark A Hull; Viktor H Koelzer; Angus G K McNair; Kevin J Monahan; Inke Näthke; Christine Norton; Marco R Novelli; Robert J C Steele; Anne L Thomas; Lisa M Wilde; Richard H Wilson; Ian Tomlinson
Journal:  Gut       Date:  2018-01       Impact factor: 23.059

Review 6.  Effects of the intestinal microbial metabolite butyrate on the development of colorectal cancer.

Authors:  Xinqiang Wu; Yuanbing Wu; Liangmei He; Longhuo Wu; Xiangcai Wang; Zhiping Liu
Journal:  J Cancer       Date:  2018-06-15       Impact factor: 4.207

Review 7.  Interplay between Dietary Polyphenols and Oral and Gut Microbiota in the Development of Colorectal Cancer.

Authors:  Carolina Cueva; Mariana Silva; Iris Pinillos; Begoña Bartolomé; M Victoria Moreno-Arribas
Journal:  Nutrients       Date:  2020-02-27       Impact factor: 5.717

Review 8.  Understanding the Mechanisms of Diet and Outcomes in Colon, Prostate, and Breast Cancer; Malignant Gliomas; and Cancer Patients on Immunotherapy.

Authors:  Shivtaj Mann; Manreet Sidhu; Krisstina Gowin
Journal:  Nutrients       Date:  2020-07-26       Impact factor: 5.717

9.  Rubidium chloride modulated the fecal microbiota community in mice.

Authors:  Qian Chen; Zhiguo He; Yuting Zhuo; Shuzhen Li; Wenjing Yang; Liang Hu; Hui Zhong
Journal:  BMC Microbiol       Date:  2021-02-15       Impact factor: 3.605

10.  Butyrate enhances the efficacy of radiotherapy via FOXO3A in colorectal cancer patient‑derived organoids.

Authors:  Misun Park; Junhye Kwon; Hye-Jin Shin; Sun Mi Moon; Sang Bum Kim; Ui Sup Shin; Young-Hoon Han; Younjoo Kim
Journal:  Int J Oncol       Date:  2020-10-13       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.